Neurobiological trait abnormalities in bipolar disorder

[1]  I. Heuser,et al.  Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol , 2009, Molecular Psychiatry.

[2]  R. Murray,et al.  Genetic Liability for Bipolar Disorder Is Characterized by Excess Frontal Activation in Response to a Working Memory Task , 2008, Biological Psychiatry.

[3]  Steven C. R. Williams,et al.  Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. , 2008, Archives of general psychiatry.

[4]  M L Phillips,et al.  Neural systems underlying voluntary and automatic emotion regulation: toward a neural model of bipolar disorder , 2008, Molecular Psychiatry.

[5]  H. Lôo.  [On bipolar disorder]. , 2008, L'Encephale.

[6]  Kiralee M. Hayashi,et al.  Three-Dimensional Mapping of Hippocampal Anatomy in Unmedicated and Lithium-Treated Patients with Bipolar Disorder , 2008, Neuropsychopharmacology.

[7]  J. Warsh,et al.  Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder. , 2008, The international journal of neuropsychopharmacology.

[8]  J. Port,et al.  Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study , 2008, Psychiatry Research: Neuroimaging.

[9]  W. Regenold.  Lithium and Increased Cortical Gray Matter—More Tissue or More Water? , 2008, Biological Psychiatry.

[10]  M. Maj,et al.  Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. , 2008, Bipolar disorders.

[11]  Agatha D. Lee,et al.  Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium , 2008, Neuroreport.

[12]  T. Schneider-Axmann,et al.  Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder , 2008, Acta psychiatrica Scandinavica.

[13]  Glenda M MacQueen,et al.  Bilateral Hippocampal Volume Increase in Patients with Bipolar Disorder and Short-term Lithium Treatment , 2008, Neuropsychopharmacology.

[14]  A. Beyza,et al.  Changes in regional cerebral blood flow demonstrated by 99mTc-HMPAO SPECT in euthymic bipolar patients , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[15]  A. Mallinger,et al.  Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry study , 2007, Neuroscience Letters.

[16]  Sun-Hwa Park,et al.  Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. , 2007, Journal of affective disorders.

[17]  M. Atmaca,et al.  Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine. , 2007, Journal of Psychiatric Research.

[18]  M. Alda,et al.  Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study , 2007, Psychopharmacology.

[19]  H. Manji,et al.  In Search of the Holy Grail for the Treatment of Neurodegenerative Disorders: Has a Simple Cation Been Overlooked? , 2007, Biological Psychiatry.

[20]  Kiralee M. Hayashi,et al.  Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar Disorder , 2007, Biological Psychiatry.

[21]  M. Berk,et al.  Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder , 2007, Neuroscience Letters.

[22]  J. Lagopoulos,et al.  Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients. , 2007, Bipolar disorders.

[23]  Marc L Seal,et al.  The nature of abnormal language processing in euthymic bipolar I disorder: evidence for a relationship between task demand and prefrontal function. , 2007, Bipolar disorders.

[24]  J. Lagopoulos,et al.  An event-related functional MRI study of working memory in euthymic bipolar disorder. , 2007, Journal of psychiatry & neuroscience : JPN.

[25]  C Poupon,et al.  Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex , 2007, Molecular Psychiatry.

[26]  M. Leboyer,et al.  Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. , 2007, The American journal of psychiatry.

[27]  P. Sachdev,et al.  Regional Gray Matter Changes in Bipolar Disorder: A Voxel-Based Morphometric Study , 2007, The Australian and New Zealand journal of psychiatry.

[28]  Caleb M. Adler,et al.  Voxel-Based Study of Structural Changes in First-Episode Patients with Bipolar Disorder , 2007, Biological Psychiatry.

[29]  William D S Killgore,et al.  Reduced Amygdala Volumes in First-Episode Bipolar Disorder and Correlation with Cerebral White Matter , 2007, Biological Psychiatry.

[30]  A. Young,et al.  Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder , 2007, Schizophrenia Research.

[31]  M. Dietrich,et al.  Decreased Plasma Brain Derived Neurotrophic Factor Levels in Unmedicated Bipolar Patients During Manic Episode , 2007, Biological Psychiatry.

[32]  A. Owen,et al.  Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. , 2007, Journal of affective disorders.

[33]  W. Nolen,et al.  A relative resistance of T cells to dexamethasone in bipolar disorder. , 2006, Bipolar disorders.

[34]  M. Atmaca,et al.  Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine , 2006, Psychological Medicine.

[35]  T. Uzbay,et al.  Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  F. Mosquera,et al.  Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients , 2006, Schizophrenia Research.

[37]  D. Ankerst,et al.  Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  W. Drevets,et al.  Toward Constructing an Endophenotype Strategy for Bipolar Disorders , 2006, Biological Psychiatry.

[39]  Carmine M Pariante,et al.  The glucocorticoid receptor: part of the solution or part of the problem? , 2006, Journal of psychopharmacology.

[40]  I. Ferrier,et al.  Magnetic resonance imaging abnormalities in young euthymic patients with bipolar affective disorder , 2006, British Journal of Psychiatry.

[41]  S. Strakowski,et al.  Anterior cingulate subregion volumes and executive function in bipolar disorder. , 2006, Bipolar disorders.

[42]  B. Frey,et al.  Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes , 2006, Neuroscience Letters.

[43]  Michael P. Milham,et al.  Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry , 2006, NeuroImage.

[44]  R. Gullapalli,et al.  Diffusion-weighted magnetic resonance imaging of white matter in bipolar disorder: a pilot study. , 2006, Bipolar disorders.

[45]  I. Ferrier,et al.  Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. , 2006, Bipolar disorders.

[46]  E. Bramon,et al.  Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. , 2006, The American journal of psychiatry.

[47]  P. Scully,et al.  Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. , 2006, Journal of affective disorders.

[48]  M. Alda,et al.  Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. , 2006, The American journal of psychiatry.

[49]  P. Renshaw,et al.  Regional cerebral cortical thinning in bipolar disorder. , 2006, Bipolar disorders.

[50]  Scott K Holland,et al.  Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. , 2006, The American journal of psychiatry.

[51]  A. Young,et al.  Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function. , 2006, Bipolar disorders.

[52]  S. Rauch,et al.  Impaired Recruitment of the Dorsolateral Prefrontal Cortex and Hippocampus During Encoding in Bipolar Disorder , 2006, Biological Psychiatry.

[53]  Warren D Taylor,et al.  Cortical White Matter Microstructural Abnormalities in Bipolar Disorder , 2005, Neuropsychopharmacology.

[54]  P. Scully,et al.  Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression , 2005, Psychological Medicine.

[55]  Gin S Malhi,et al.  An emotional Stroop functional MRI study of euthymic bipolar disorder. , 2005, Bipolar disorders.

[56]  P. Renshaw,et al.  Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research , 2005, Molecular Psychiatry.

[57]  S. Holland,et al.  Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. , 2005, The American journal of psychiatry.

[58]  S. Strakowski,et al.  Changes in Gray Matter Volume in Patients with Bipolar Disorder , 2005, Biological Psychiatry.

[59]  Umapathy,et al.  Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. , 2005, Journal of psychiatric research.

[60]  Muriel Walshe,et al.  Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder , 2005, British Journal of Psychiatry.

[61]  F. Taneli,et al.  Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[62]  Cheuk Y. Tang,et al.  Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses , 2005, Biological Psychiatry.

[63]  J. Potash,et al.  Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: A pilot study , 2005, Biological Psychiatry.

[64]  R. Gallop,et al.  Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. , 2005, The American journal of psychiatry.

[65]  Marshall R. Thomas,et al.  Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[66]  R. Murray,et al.  A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. , 2004, Bipolar disorders.

[67]  V. Schmithorst,et al.  Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. , 2004, Bipolar disorders.

[68]  V. Cardenas,et al.  Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder. , 2004, Journal of affective disorders.

[69]  G J Barker,et al.  A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry. , 2004, Brain : a journal of neurology.

[70]  G. Christodoulou,et al.  Cytokine production in bipolar affective disorder patients under lithium treatment. , 2004, Journal of affective disorders.

[71]  Eve C. Johnstone,et al.  Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives , 2004, Biological Psychiatry.

[72]  P. Renshaw,et al.  White matter hyperintensities in subjects with bipolar disorder , 2004, Psychiatry and clinical neurosciences.

[73]  E. Bramon,et al.  Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. , 2004, Archives of general psychiatry.

[74]  Sophia Rabe-Hesketh,et al.  Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder , 2004, Biological Psychiatry.

[75]  J. Thakore,et al.  Evidence of basal pituitary–adrenal overactivity in first episode, drug naïve patients with schizophrenia , 2004, Psychoneuroendocrinology.

[76]  S. Holland,et al.  A Preliminary fMRI Study of Sustained Attention in Euthymic, Unmedicated Bipolar Disorder , 2004, Neuropsychopharmacology.

[77]  H. Manji,et al.  Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. , 2004, Neuron glia biology.

[78]  K. Denicoff,et al.  Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology , 2004, Molecular Psychiatry.

[79]  R. Parsey,et al.  Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry , 2004, Biological Psychiatry.

[80]  D. Glahn,et al.  The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. , 2004, Bipolar disorders.

[81]  Marko Wilke,et al.  Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study. , 2004, Bipolar disorders.

[82]  A. Young,et al.  Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder , 2004, British Journal of Psychiatry.

[83]  Yi-yuan Yang,et al.  Immunologic variables in acute mania of bipolar disorder , 2004, Journal of Neuroimmunology.

[84]  M. Schwald,et al.  The cAMP-dependent protein kinase A and brain-derived neurotrophic factor expression in lymphoblast cells of bipolar affective disorder. , 2004, Journal of affective disorders.

[85]  M. Schwald,et al.  Drug-Induced Decrease of Protein Kinase A Activity Reveals Alteration in BDNF Expression of Bipolar Affective Disorder , 2004, Neuropsychopharmacology.

[86]  M. Phillips,et al.  Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression , 2004, Biological Psychiatry.

[87]  Stephan Heckers,et al.  Molecular evidence for mitochondrial dysfunction in bipolar disorder. , 2004, Archives of general psychiatry.

[88]  Gareth J. Barker,et al.  A diffusion tensor imaging study of schizophrenia , 2004 .

[89]  N. Kato,et al.  Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. , 2003, The international journal of neuropsychopharmacology.

[90]  H. Mayberg,et al.  State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge , 2003, Biological Psychiatry.

[91]  J. Gore,et al.  Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. , 2003, Archives of general psychiatry.

[92]  Ravi S. Menon,et al.  An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. , 2003, Journal of affective disorders.

[93]  Tyrone D. Cannon,et al.  Reduced left hemispheric white matter volume in twins with bipolar I disorder , 2003, Biological Psychiatry.

[94]  E. Smeraldi,et al.  Protein kinase A activity in platelets from patients with bipolar disorder. , 2003, Journal of Affective Disorders.

[95]  S. Rauch,et al.  Neurobiology of emotion perception II: implications for major psychiatric disorders , 2003, Biological Psychiatry.

[96]  H. Manji,et al.  The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation , 2003, The Journal of Neuroscience.

[97]  D. Kupfer,et al.  MRI investigation of temporal lobe structures in bipolar patients. , 2003, Journal of psychiatric research.

[98]  P. Skudlarski,et al.  A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. , 2003, Archives of general psychiatry.

[99]  C. Hanstock,et al.  Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients , 2003, International clinical psychopharmacology.

[100]  S. Checkley,et al.  Altered glucocorticoid immunoregulation in treatment resistant depression , 2003, Psychoneuroendocrinology.

[101]  R. Post,et al.  High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder , 2003, Biological Psychiatry.

[102]  Sophia Frangou,et al.  Neuropsychology of bipolar disorder: a review. , 2002, Journal of affective disorders.

[103]  Stephen M Strakowski,et al.  Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. , 2002, The American journal of psychiatry.

[104]  Ellen Frank,et al.  Anatomical MRI Study of Subgenual Prefrontal Cortex in Bipolar and Unipolar Subjects , 2002, Neuropsychopharmacology.

[105]  A. Åberg-Wistedt,et al.  Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[106]  Ronald Glaser,et al.  Depression and immune function: central pathways to morbidity and mortality. , 2002, Journal of psychosomatic research.

[107]  S. Strakowski,et al.  Regional prefrontal gray and white matter abnormalities in bipolar disorder , 2002, Biological Psychiatry.

[108]  S. Beaulieu,et al.  The neurobiology of treatment response to antidepressants and mood stabilizing medications. , 2002, Journal of psychiatry & neuroscience : JPN.

[109]  Yarema Bezchlibnyk,et al.  The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[110]  J. Lewin,et al.  Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder , 2002, Psychiatry Research: Neuroimaging.

[111]  M. Alda,et al.  Is lithium response related to Gsα levels in transformed lymphoblasts from subjects with bipolar disorder , 2001 .

[112]  P. Renshaw,et al.  31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis , 2001, Psychiatry Research: Neuroimaging.

[113]  D. Kupfer,et al.  Increased platelet membrane phosphatidylinositol-4,5-bisphosphate in drug-free depressed bipolar patients , 2001, Neuroscience Letters.

[114]  Jane Epstein,et al.  Increased anterior cingulate and caudate activity in bipolar mania , 2000, Biological Psychiatry.

[115]  G. Moore,et al.  Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic–depressive illness , 2000, Biological Psychiatry.

[116]  G. Moore,et al.  Lithium-induced increase in human brain grey matter , 2000, The Lancet.

[117]  L. Altshuler,et al.  MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. , 2000, Journal of affective disorders.

[118]  S. Parikh,et al.  Associated disturbances in calcium homeostasis and G protein–mediated cAMP signaling in bipolar I disorder , 2000, Biological Psychiatry.

[119]  H. Manji,et al.  Signaling: cellular insights into the pathophysiology of bipolar disorder , 2000, Biological Psychiatry.

[120]  G. Bartzokis,et al.  An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia , 2000, Biological Psychiatry.

[121]  J. Seibyl,et al.  Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. , 2000, The American journal of psychiatry.

[122]  Guang Chen,et al.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? , 2000, Biological Psychiatry.

[123]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[124]  E. Frank,et al.  Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: a pilot study , 2000, Psychopharmacology.

[125]  M E Newman,et al.  Illness, Cytokines, and Depression , 2000, Annals of the New York Academy of Sciences.

[126]  H. Manji,et al.  The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3 , 2000, Journal of neurochemistry.

[127]  E Stern,et al.  Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. , 1999, The American journal of psychiatry.

[128]  J. Rybakowski,et al.  The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. , 1999, Journal of psychiatric research.

[129]  B. Stanton,et al.  Neuropsychological function in euthymic patients with bipolar disorder , 1999, British Journal of Psychiatry.

[130]  S. Schulz,et al.  Meta-analysis of brain size in bipolar disorder , 1999, Schizophrenia Research.

[131]  D. Levinson,et al.  Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. , 1999, Journal of psychiatric research.

[132]  E. Smeraldi,et al.  Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. , 1999, Archives of general psychiatry.

[133]  S. Strakowski,et al.  Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. , 1999, Archives of general psychiatry.

[134]  D. Kupfer,et al.  Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment? , 1999, Biological Psychiatry.

[135]  H. Manji,et al.  The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS , 1999, Journal of neurochemistry.

[136]  M. Maes,et al.  Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.

[137]  A. Turnbull,et al.  Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. , 1999, Physiological reviews.

[138]  K. Krishnan,et al.  Familial leukoencephalopathy in bipolar disorder. , 1998, The American journal of psychiatry.

[139]  G. Bartzokis,et al.  Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. , 1998, Archives of general psychiatry.

[140]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[141]  N. Kato,et al.  Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[142]  S. Parikh,et al.  High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. , 1997, The American journal of psychiatry.

[143]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[144]  S. Avissar,et al.  Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. , 1997, Journal of affective disorders.

[145]  Mark E. Schmidt,et al.  High Levels of Gsα in Platelets of Euthymic Patients With Bipolar Affective Disorder , 1997 .

[146]  H. Meltzer,et al.  Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs , 1997, Psychiatry Research.

[147]  G. Pearlson,et al.  Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder , 1997, Biological Psychiatry.

[148]  T. Inubushi,et al.  Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. , 1996, Journal of psychiatry & neuroscience : JPN.

[149]  H. Besedovsky,et al.  Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.

[150]  I. Heuser,et al.  Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I , 1995, Biological Psychiatry.

[151]  A. Turnbull,et al.  Regulation of the HPA Axis by Cytokines , 1995, Brain, Behavior, and Immunity.

[152]  C. Hammen,et al.  Relapse and impairment in bipolar disorder. , 1995, The American journal of psychiatry.

[153]  L. Friedman,et al.  Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. , 1995, Archives of general psychiatry.

[154]  L. Altshuler,et al.  T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. , 1995, The American journal of psychiatry.

[155]  H. Manji,et al.  Signal transduction pathways. Molecular targets for lithium's actions. , 1995, Archives of general psychiatry.

[156]  F. Holsboer,et al.  Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. , 1995, Neuroendocrinology.

[157]  G. Fein,et al.  Abnormal frontal lobe phosphorous metabolism in bipolar disorder. , 1995, The American journal of psychiatry.

[158]  L. Altshuler.  Premenstrual Dysphonias: Myths and Realities , 1995 .

[159]  G. Fein,et al.  Decreased temporal lobe phosphomonoesters in bipolar disorder. , 1995, Journal of affective disorders.

[160]  J. Calabrese,et al.  Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. , 1995, Journal of psychiatric research.

[161]  J. Hsiao,et al.  Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment. , 1995, Archives of general psychiatry.

[162]  I. Heuser,et al.  The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. , 1994, Journal of psychiatric research.

[163]  T. Inubushi,et al.  Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. , 1994, Journal of affective disorders.

[164]  B. Leonard,et al.  Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. , 1994, Journal of affective disorders.

[165]  J. Warsh,et al.  Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. , 1994, American Journal of Psychiatry.

[166]  A. Mallinger,et al.  Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania. , 1993, The American journal of psychiatry.

[167]  T. Inubushi,et al.  Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. , 1992, Journal of affective disorders.

[168]  R. Belmaker,et al.  Hyperfunctional G proteins in mononuclear leukocytes of patients with mania , 1991, Biological Psychiatry.

[169]  F. Holsboer,et al.  Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression Implications for pathophysiology of DST nonsuppression , 1987, Biological Psychiatry.

[170]  R. Langevin,et al.  Neuropsychological impairment in pedophiles. , 1986 .

[171]  B. Carroll.  Use of the dexamethasone suppression test in depression. , 1982, The Journal of clinical psychiatry.

[172]  M. Berridge,et al.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. , 1982, The Biochemical journal.

[173]  G. Pearlson,et al.  COMPUTERISED TOMOGRAPHIC SCAN CHANGES IN MANIC-DEPRESSIVE ILLNESS , 1981, The Lancet.

[174]  P. McHugh,et al.  Plasma cortisol in depressive illness. , 1962, Journal of psychiatric research.